Oncology
Solid tumors, hematologic malignancies, and immuno-oncology therapies targeting cancer cell survival and proliferation.
Core & active disease programs
Provisional & emerging programs (56)Early clinical pipeline & single-asset indications
Colorectal Cancer
Solid Tumors
Ovarian Cancer
Prostate Cancer
Melanoma
Hepatocellular Carcinoma
Renal Cell Carcinoma
Gastric Cancer
Non-Hodgkin Lymphoma
Bladder / Urothelial Cancer
Cervical Cancer
Small Cell Lung Cancer
Biliary Tract Cancer
Chronic Lymphocytic Leukemia
Glioblastoma
Metastatic Castration-Resistant Prostate Cancer
Pancreatic Ductal Adenocarcinoma
Endometrial Cancer
Diffuse Large B-Cell Lymphoma
Head and Neck Squamous Cell Carcinoma
Bladder Cancer
Pancreatic Cancer
Follicular Lymphoma
Myelodysplastic Syndromes
Esophageal Cancer
Glioma
Mantle Cell Lymphoma
Nasopharyngeal Carcinoma
Acute Lymphoblastic Leukemia
Myelofibrosis
Soft Tissue Sarcoma
Polycythemia Vera
Cutaneous T-Cell Lymphoma
Merkel Cell Carcinoma
Uveal Melanoma
Chronic Myeloid Leukemia
Essential Thrombocythemia
Gastrointestinal Stromal Tumor
Systemic Mastocytosis
Brain Cancer
Hematologic Malignancies
Anal Cancer
Bone Cancer
Bone Metastases from Solid Tumors
Brain Metastases
Cancer Cachexia
Chemotherapy-Induced Nausea and Vomiting
Classical Hodgkin Lymphoma
Gastroenteropancreatic Neuroendocrine Tumors
Neuroblastoma
Oropharyngeal Cancer
Rectal Cancer
Waldenstrom's Macroglobulinemia
B-Cell Lymphoma
Central Nervous System Tumors
Neuroendocrine Tumors